By Marisa Wong
Madison, Wis., July 15 – Religare Health Trust announced it priced S$60 million of 4˝% fixed-rate notes due 2018.
This is the first series of notes to be issued under the company’s S$500 million multicurrency medium-term note program established on Dec. 5, 2014.
DBS Bank Ltd., Deutsche Bank AG, Singapore Branch, Standard Chartered Bank and Religare Capital Markets (Singapore) Pte. Ltd. are the joint lead managers and joint bookrunners for the offering.
Proceeds from the series 001 notes will be used for refinancing or repaying existing borrowings and general working capital.
Settlement is slated for July 22.
The Singapore-based business trust is managed by Religare Health Trust Trustee Manager Pte. Ltd., which is a wholly owned subsidiary of Religare Enterprises Ltd., a financial services group based in New Delhi.
| Issuer: | Religare Health Trust
|
| Issue: | Fixed-rate medium-term notes, series 001
|
| Amount: | S$60 million
|
| Maturity: | 2018
|
| Coupon: | 4˝%
|
| Bookrunners: | DBS Bank Ltd., Deutsche Bank AG, Singapore Branch, Standard Chartered Bank and Religare Capital Markets (Singapore) Pte. Ltd.
|
| Announcement date: | July 15
|
| Settlement date: | July 22
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
